FA
ATRC icon

Friess Associates’s AtriCure ATRC Stock Holding History

Friess Associates’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-32,150
Closed -$541K – 142
2016
Q1 		$541K Hold
32,150
– – 0.05% 107
2015
Q4 		$721K Buy
32,150
+12,150
+61% +$250K 0.07% 89
2015
Q3 		$438K Buy
+20,000
New +$500K 0.04% 112

Other funds holding ATRC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Friess Associates's ATRC Position: Q2 2016 in Review

Friess Associates sold out of AtriCure (ATRC) in Q2 2016, closing a stake of 32,150 shares — an estimated $541K sold.

Friess Associates first reported a position in ATRC in Q3 2015 and held it in 3 quarters. The position peaked at $721K in Q4 2015. 102 funds tracked by Wall St. Rank hold ATRC as of Q2 2016.

  • Friess Associates reported no remaining AtriCure position as of Q2 2016 after selling out during the quarter.
  • Friess Associates sold 32,150 AtriCure shares in Q2 2016, an estimated $541K.
  • Friess Associates first reported a position in AtriCure in Q3 2015 and held it in 3 quarters.
  • Friess Associates's AtriCure position peaked at $721K in Q4 2015.
  • 102 funds tracked by Wall St. Rank held AtriCure as of Q2 2016.

Based on Friess Associates's 13F filing for Q2 2016, filed 12 Aug 2016.